Inpharma Weekly

, Volume 963, Issue 1, pp 14–14 | Cite as

No advantage with IP cisplatin

Newsletter Article

Keywords

Ovarian Cancer Disease Recurrence Thiosulfate Evaluable Patient Intraperitoneal Chemotherapy 

Copyright information

© Adis International Ltd 1994

Personalised recommendations